Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/2012
12/27/2012CA2839674A1 Composition and formulation comprising recombinant human iduronate-2-sulfatase and preparation method thereof
12/27/2012CA2839634A1 Methods for the production of a cosmetic composition comprising leukolectin and uses thereof
12/27/2012CA2839630A1 Combination therapy for ischemia
12/27/2012CA2839558A1 Leukotoxin e/d as a new anti-inflammatory agent and microbicide
12/27/2012CA2839554A1 Methods of treating and preventing staphylococcus aureus infections and associated conditions
12/27/2012CA2839343A1 Biocompatible film with variable cross-sectional properties
12/27/2012CA2839142A1 Bioresorbable wound dressing
12/27/2012CA2839024A1 Modified antibiotic peptides having variable systemic release
12/27/2012CA2837658A1 Pcsk9-binding polypeptides and methods of use
12/27/2012CA2837651A1 Compositions and methods for the therapy and diagnosis of cancer
12/26/2012EP2537933A1 An IL-15 and IL-15Ralpha sushi domain based immunocytokines
12/26/2012EP2537927A1 Polynucleotide encoding acyl-coa synthetase homolog and method for using the same
12/26/2012EP2537857A2 Mutant forms of streptolysin O
12/26/2012EP2537856A1 Method for preparing atosiban acetate
12/26/2012EP2537538A1 Bioresorbable Wound Dressing
12/26/2012EP2537534A1 Prodrugs of (1S,9S)-9-[[(1S)-1-carboxy-3-phenylpropyl]amino]octahydro-10-oxo-6H-pyridazino[1,2-a][1,2]diazepine-1-carboxylic acid and their use in transdermal therapeutic systems
12/26/2012EP2537528A1 Pharmaceutical or nutritional compositions containing galactosidase, and their use
12/26/2012EP2537527A2 Uses of recombinant super-compound interferons
12/26/2012EP2537526A1 Method and compound for the treatment of valvular stenosis
12/26/2012EP2537525A1 Diagnosis and prognosis of colorectal cancer
12/26/2012EP2537524A2 Treatment of T-cell mediated diseases
12/26/2012EP2537031A1 Compositions and methods for treating cancer
12/26/2012EP2536830A1 Polypeptides
12/26/2012EP2536827A1 Methods of manufacture of therapeutic products comprising vitalized placental dispersions
12/26/2012EP2536826A1 Therapeutic products comprising vitalized placental dispersions
12/26/2012EP2536825A1 Immunocompatible amniotic membrane products
12/26/2012EP2536824A1 Immunocompatible chorionic membrane products
12/26/2012EP2536823A1 Methods of manufacture of immunocompatible chorionic membrane products
12/26/2012EP2536763A1 Activatable constructs
12/26/2012EP2536757A1 Fibronectin based scaffold domain proteins that bind il-23
12/26/2012EP2536756A1 Hsa-related compositions and methods of use
12/26/2012EP2536755A1 Conjugated fviii variants
12/26/2012EP2536753A1 Factor viii molecules with reduced vwf binding
12/26/2012EP2536749A1 Methods for preparing human growth hormone
12/26/2012EP2536748A1 Neuregulin antagonists and use thereof in treating cancer
12/26/2012EP2536741A2 Gene fusion targeted therapy
12/26/2012EP2536433A2 Epithelial membrane protein 2 (emp2) binding reagents and their therapeutic uses in ocular diseases
12/26/2012EP2536426A1 A pharmaceutical composition for treatment of thrombosis-related diseases comprising a fragment of prolactin (prl)-growth hormone (gh)-placental lactogen (pl)-family protein
12/26/2012EP2536425A2 Vaccines for use in the prophylaxis and treatment of influenza virus disease
12/26/2012EP2536424A2 Use of rho gtpase activating toxines for the treatment and/or prevention of symptomatology associated with rett syndrome
12/26/2012EP2536423A2 SUPPRESSORS OF RNA SILENCING AS MODULATORS OF miRNA LEVELS
12/26/2012EP2536422A2 Methods for treating diabetic foot ulcers
12/26/2012EP2536421A2 Method for treatment of psoriasis
12/26/2012EP2536420A1 Use of pten-long leader sequence for transmembrane delivery of molecules
12/26/2012EP2536419A1 Transferrin for use in the treatment and/or prophylaxis of autoimmune diseases
12/26/2012EP2536417A1 Methods of manufacture of immunocompatible amniotic membrane products
12/26/2012EP2536406A2 Bismuth-thiols as antiseptics for biomedical uses, including treatment of bacterial biofilms and other uses
12/26/2012CN202620280U Novel capsule filled with perindopril solid preparation and indapamide solid preparation
12/26/2012CN102844044A Chlorotoxin polypeptides and conjugates and uses thereof
12/26/2012CN102844043A Use of pten-long leader sequence for transmembrane delivery of molecules
12/26/2012CN102843920A Liquid enteral nutritional composition suitable for tube feeding, minimizing lower and upper tract digestive conditions
12/26/2012CN102839206A Preparation method for promoting self generation of human bone marrow hematopoietic stem cells
12/26/2012CN102839194A Recombinant adeno-associated virus vector, and preparation method and application thereof
12/26/2012CN102839186A Preparation and application of recombinant Mycobacterium smegmatis expressing NY-ESO-1
12/26/2012CN102839185A Construction method and application technology of rolGLP-HV engineering bacterium
12/26/2012CN102838679A Preparation and application of Her2-neu antigen positive tumor therapeutic vaccine
12/26/2012CN102838678A 重组促红细胞生成素及制备方法 Recombinant erythropoietin and preparation methods
12/26/2012CN102838677A 重组促红细胞生成素及制备方法 Recombinant erythropoietin and preparation methods
12/26/2012CN102838671A Growth hormone with site-specific mutagenesis and site-specific decoration, preparation method and applications of growth hormone
12/26/2012CN102838669A Valosin fragment, and preparation method and application thereof
12/26/2012CN102838667A Preparation method of iron protein succinylate
12/26/2012CN102838661A Vancomycin or demethyl vancomycin analogue and medicinal uses thereof
12/26/2012CN102838660A Small molecule polypeptides with function of inflammation immune reaction inhibition, and applications thereof
12/26/2012CN102838658A Treatment of inflammation and/or endotoxic shock
12/26/2012CN102838654A Method for the synthesis of a bifunctional complex
12/26/2012CN102836441A Method for enhancing immune response in treatment of infectious and malignant disease
12/26/2012CN102836438A Multi-component biological transport systems
12/26/2012CN102836422A Disease prevention and growth promotion magic drug
12/26/2012CN102836421A Intestinal environment-improving agent
12/26/2012CN102836420A Methods and compositions involving MDA-7
12/26/2012CN102836419A Iron protein succinylate oral solution and preparation method thereof
12/26/2012CN102836418A Pingyangmycin polyethylene glycol (PEG)-polycaprolactone (PCL)-polyethylene glycol (PEG) temperature-sensitive slow-release gel, as well as preparation method and application of same
12/26/2012CN102836417A Drug composition for treating white scour of piglets and preparation method thereof
12/26/2012CN102836416A Bionic enzymolysis preparation method of leech powder
12/26/2012CN102836415A Composition for enhancing immune activity, medical composition for preventing and improving cancer
12/26/2012CN102836414A External Chinese medicinal oil for treating herpes zoster, burn and scald and bedsore
12/26/2012CN102836221A Composition containing Armillaria mellea and combination of one or several of Melissa, lavender, chrysanthemum and jasmine
12/26/2012CN102836126A Preparation method of artificial red blood cell universal for animals
12/26/2012CN102406943B Polyethylene glycol chemically modified compound of human fibroblast growth factor-21 (FGF-21) and preparation method thereof
12/26/2012CN102309751B Superoxide dismutase (SOD) composite capsule and preparation method thereof
12/26/2012CN102266272B Personal care composition and products
12/26/2012CN102178935B Preparation for resisting radiation, enhancing body immunity and preventing and treating tumors
12/26/2012CN102178934B Preparation for increasing bone mineral density, preventing osteoarthrosis and enhancing immunity
12/26/2012CN102178932B Preparation for relieving fatigue and enhancing immunity
12/26/2012CN102102119B Bird's nest oligopeptide composition and preparation method and use thereof
12/26/2012CN102049034B Hoof nail polypeptide preparation for promoting tissue repair and preparation method thereof
12/26/2012CN102038939B Preparation method of adenosine triphosphate coenzyme insulin freeze-dried powder injection
12/26/2012CN102008712B Trandolapril-containing compound preparation for curing hypertension
12/26/2012CN102008711B Compound preparation containing enalapril for treating hypertension
12/26/2012CN102008709B Moexipril-contained compound preparation for treating hypertension
12/26/2012CN102008707B Quinapril-contained compound preparation for treating hypertension
12/26/2012CN101939020B Application of degarelix in preparing medicine of metastatic stage prostate cancer
12/26/2012CN101934067B Preparation method of polygeline injection
12/26/2012CN101891804B Antisense peptide nucleic acid of cell penetrating peptide-mediated antibacterial RNA polymerase sigma 70 factor gene rpoD
12/26/2012CN101863985B Recombinant human fusion Tat cytoglobulin and application thereof in treating liver cancer
12/26/2012CN101687046B Pharmaceutical liquid composition of botulinum toxin with improved stability
12/26/2012CN101575377B Human cytokine as ligand of zalpha receptor and use thereof
12/26/2012CN101568550B Peptide vaccines for cancers expressing mphosph1 or depdc1 polypeptides
12/26/2012CN101484187B Compositions comprising a dissociated glucocorticoid receptor agonist and an immunosuppressive agent for treating dry eye
12/26/2012CN101484181B Recombinant host for producing l-asparaginase ii
1 ... 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 ... 3163